September 28, 2021

Volume XI, Number 271

Advertisement

September 27, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
28
Jul
Applying for a License to Dispense Medical Cannabis in Alabama Bradley Arant Boult Cummings LLP
27
Jul
Connecticut Legislature Passes Act to Help Address the Opioid Epidemic Robinson & Cole LLP
27
Jul
Upcoming AAFCO Meeting to Discuss Guidelines for “Human Grade” Claim on Animal Food Keller and Heckman LLP
26
Jul
Updated Generic HACCP Model for Beef Slaughter Keller and Heckman LLP
23
Jul
House Revives and Passes PFAS Bill Keller and Heckman LLP
23
Jul
Update on the Legalization of Marijuana in Connecticut Wilson Elser Moskowitz Edelman & Dicker LLP
22
Jul
Amidst Uncertainty Surrounding the Scope of BIPA Liability, Hyatt Settles Employee Biometric Data Class Claims for $1.5 Million Hunton Andrews Kurth
22
Jul
Applying for a License to Process Medical Cannabis in Alabama Bradley Arant Boult Cummings LLP
22
Jul
Kraft Heinz Deceptive Labeling Settlement Approved Keller and Heckman LLP
21
Jul
ECHA Calls for Tenders to Perform Study on Impact of Graphene, Graphene Oxide, and Other 2D Materials Bergeson & Campbell, P.C.
21
Jul
How Are Colorants for Food Packaging Regulated in Japan? Keller and Heckman LLP
21
Jul
Are You a Medical Device Servicer or Remanufacturer? FDA’s New Guidance May Help…Or Not Mintz
21
Jul
Federal Circuit Invalidates Device Patent As Directed to an Abstract Idea Proskauer Rose LLP
21
Jul
Lawsuit Targets Dreyer’s “Chocolate” Ice Cream Bars Keller and Heckman LLP
21
Jul
“Commercially Reasonable Efforts” Clauses in Drug Development Deals: What Level of Protection Do They Really Provide? Proskauer Rose LLP
21
Jul
Five Things to Know About the Changes to China's Medical Device Regulation K&L Gates
20
Jul
U.S. Senate’s Cannabis Administration and Opportunity Act Clarifies How Federal Government May Regulate Marijuana, but Leaves Unanswered Questions Wilson Elser Moskowitz Edelman & Dicker LLP
20
Jul
New Ohio Law Restricts Ability of Public Schools, Colleges to Mandate COVID-19 Vaccinations Jackson Lewis P.C.
20
Jul
New TSCA Section 8(d) Rule Adds 50 Chemicals to Reporting Requirements Beveridge & Diamond PC
20
Jul
Biden Administration Takes Aim at Rising Drug Prices through its Executive Order on Promoting Competition Mintz

Pages